Skip to main content
. 2003 Nov 28;2:16. doi: 10.1186/1475-2840-2-16

Table 2.

Baseline Echocardiographic Parameters

Trimetazidine Placebo
LA (mm) 52.6 ± 2.1 51.9 ± 1.7
LVEDD (mm) 63.2 ± 2.1 62.4 ± 1.7
LVESD (mm) 41.1 ± 1.5 39.5 ± 1.3
LVEF (%) 32.3 ± 5.3 32.8 ± 2.3
LV Wall Motion Index Score 1.37 ± 0.2 1.38 ± 0.3
E/A 0.68 ± 0.1 0.64 ± 0.12

Baseline echocardiographic parameters in patients randomized to trimetazidine or placebo. No significant differences in echocardiographic and Doppler measures were found between the two groups at baseline.